Calliditas Therapeutics AB
STO:CALTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Calliditas Therapeutics AB
STO:CALTX
|
SE |
|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
CN |
|
L
|
Laybuy Holdings Ltd
ASX:LBY
|
NZ |
|
V
|
Vaxtex Cotfab Ltd
NSE:VCL
|
IN |
|
iFabric Corp
TSX:IFA
|
CA |
|
C
|
CircuTech International Holdings Ltd
HKEX:8051
|
HK |
|
T
|
Ta Yang Group Holdings Ltd
HKEX:1991
|
CN |
|
Rosetti Marino SpA
MIL:YRM
|
IT |
|
Prestige Wealth Inc
NASDAQ:AURE
|
HK |
|
Sparebanken Ost
OSE:SPOG
|
NO |
|
Redwire Corp
NYSE:RDW
|
US |
|
L
|
Lumina Group Ltd
HKEX:1162
|
HK |
|
E
|
Exxaro Resources Ltd
JSE:EXX
|
ZA |
Bankruptcy Probability
Calliditas Therapeutics AB's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Calliditas Therapeutics AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Calliditas Therapeutics AB
STO:CALTX
|
12.5B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Calliditas Therapeutics AB's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Calliditas Therapeutics AB has total debt of 1B SEK. This includes both short-term (0 SEK) and long-term (1B SEK) debt.
You can find a full breakdown on its Balance Sheet.
